Why Are Uterine Balloon Stents Used After Asherman Surgery?
At a Glance
After Asherman syndrome surgery, a temporary uterine balloon stent holds the healing uterine walls apart to help reduce new scar bands. It does not remove existing scar tissue, and follow-up care is still needed because adhesions can return.
In this answer
3 sections
Surgery to remove scar tissue (adhesiolysis) is the main treatment for Asherman syndrome, but the surgery itself creates new healing areas inside the uterus. As these treated surfaces heal, they can stick back together and form new bands of scar tissue. To help prevent this, doctors often use anti-adhesion barriers—such as temporary uterine balloon stents or special gels—to physically hold the uterine walls apart while they heal [1].
Understanding how these barriers work can help reduce the anxiety of waking up with a balloon catheter in your uterus. The device is not treating the scar tissue itself; instead, it acts as a temporary spacer to help reduce contact between the walls during the early healing phase [1].
The Challenge of Healing After Surgery
The inside of the uterus is normally a potential space, meaning the front and back walls touch each other. When a surgeon cuts away scar tissue, they leave behind freshly treated surfaces on opposing walls. If these surfaces rest directly against each other during the early stages of healing, the body may bridge the gap with new scar tissue.
By placing a physical barrier inside the uterus immediately after surgery, the doctor helps keep the healing surfaces apart so they can recover independently [1].
Commonly Used Physical Barriers
Doctors rely on two main approaches to separate the uterine walls: mechanical spacers (like balloons) and coating gels. Not every patient receives a balloon or gel; the choice depends on the severity of your adhesions, your surgeon’s experience, and their specific postoperative protocol [2][3].
Uterine Balloon Stents
A uterine balloon stent is a soft, flexible catheter inserted into the uterine cavity and inflated with sterile fluid. It acts as an internal spacer, occupying the cavity to keep the newly treated surfaces from touching [1].
Commonly used balloons include:
- Foley catheter balloons: Originally designed for the bladder, these have a round balloon at the tip and are widely used as temporary uterine spacers [1].
- Cook intrauterine balloons: These are purpose-designed balloons shaped more like the natural triangular cavity of the uterus [1].
Both devices are intended to provide a physical blockade against scar bridging.
Hyaluronic Acid Gels
Instead of, or in addition to, a solid spacer, some surgeons use hyaluronic acid (HA) gel. Hyaluronic acid is a natural substance that helps retain moisture in tissues.
When applied after surgery, HA gel forms a thick, viscous coating over the treated surfaces [4]. It acts as a temporary hydrogel barrier, reducing direct contact between the uterine walls [4]. Research across various intrauterine surgeries suggests HA gels can reduce the formation of postoperative adhesions [5]. However, in trials looking specifically at Asherman syndrome surgery, the benefits are less consistent, and it is not proven to guarantee better pregnancy or live-birth rates [6].
Some surgeons use a balloon and a gel together, though research does not point to a single method that is clearly superior for every patient [2][3].
What to Expect: Care and Recovery
If a balloon stent is placed, it is a temporary measure. A tube will extend through your cervix and out of your vagina, which can cause cramping or discomfort.
Duration of Placement
The length of time the balloon stays in place varies widely based on the specific device and the severity of the adhesions. Seven days is a conventional and common duration [7]. However, some studies evaluate leaving balloons in place for 4 to 8 weeks for severe adhesions, particularly depending on whether a Foley or Cook balloon is used [7][8]. Prolonged placement is not always better, as longer durations with some purpose-designed balloons might adversely affect later pregnancy outcomes [9]. Your surgeon will determine the safest duration for your specific situation.
Medications and Restrictions
While the balloon is in place:
- Medications: Your doctor will likely recommend pain relief. Depending on their clinical assessment and protocol, they may also prescribe antibiotics to reduce the risk of infection, as bacteria can colonize the balloon [10]. Estrogen or other hormones are also frequently prescribed as part of a broader plan to encourage the uterine lining to heal [2].
- Activity: You must use strict contraception to avoid pregnancy while the device is in place [11]. You should also ask your surgeon for specific restrictions regarding sexual intercourse, tampons, douching, swimming, and heavy lifting, as protocols vary.
Warning Signs
If you go home with a balloon stent, contact your surgical team promptly if you experience:
- Fever or chills
- Worsening or severe pelvic pain
- Foul-smelling vaginal discharge
- Unexpectedly heavy bleeding
- The balloon or tube falling out or moving significantly
Do not attempt to push the balloon back in or remove it yourself. Only a healthcare professional should adjust or remove the device.
Follow-Up Care
A balloon or gel is not a guarantee that adhesions will not return [12]. Because recurrence is possible, your balloon placement is typically just one part of a comprehensive recovery plan. Many surgeons recommend a follow-up assessment—such as a second-look hysteroscopy (a camera examination of the uterine cavity)—to check how the walls are healing and to treat any mild new adhesions before they become severe [12].
Common questions in this guide
Why is a balloon placed after Asherman syndrome surgery?
How long does a uterine balloon stay in place?
What does a uterine balloon feel like after surgery?
What should I do if the balloon falls out or I develop warning signs?
Can uterine balloon stents prevent Asherman syndrome from coming back?
Can I become pregnant while a uterine balloon is in place?
Is hyaluronic acid gel better than a uterine balloon after Asherman surgery?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which temporary barrier (Foley, Cook balloon, or gel) will you use for my surgery, and why is it preferred for my specific adhesion severity?
- 2.Exactly how long will the balloon stay in my uterus, and where will it be removed?
- 3.Will you prescribe antibiotics or hormones as part of my postoperative recovery plan?
- 4.What specific warning signs (like fever, pain, or heavy bleeding) should prompt me to contact the care team urgently?
- 5.What are my restrictions regarding intercourse, tampons, and bathing while the device is in place?
- 6.When will we assess the cavity to see how it is healing, and when is it medically safe to attempt pregnancy?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
Focus on the Primary Prevention of Intrauterine Adhesions: Current Concept and Vision.
Lee WL, Liu CH, Cheng M, et al.
International journal of molecular sciences 2021; (22(10)) doi:10.3390/ijms22105175.
PMID: 34068335 - 2
Supplements to Conventional Treatment After Hysteroscopic Lysis of Intrauterine Adhesions: A Systematic Review.
Konci R, Caminsky N, Tulandi T, Dahan MH
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2020; (42(8)):984-1000 doi:10.1016/j.jogc.2019.09.008.
PMID: 31882284 - 3
Adjuvants to prevent reformation of adhesions following adhesiolysis for Asherman syndrome: a systematic review and meta-analysis.
Guo J, Shi X, Yu F, et al.
Human fertility (Cambridge, England) 2023; (26(4)):797-814 doi:10.1080/14647273.2023.2254492.
PMID: 37778374 - 4
Hydrogel-Based Systems in Intrauterine Adhesions: Bridging the Gap from Bench to Bedside.
Zhao Y, Tan D, Weng Y, et al.
Advanced healthcare materials 2026; (15(30)):e71362 doi:10.1002/adhm.71362.
PMID: 42415487 - 5
Effects and safety of hyaluronic acid gel on intrauterine adhesion and fertility after intrauterine surgery: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials.
Luo Y, Sun Y, Huang B, et al.
American journal of obstetrics and gynecology 2024; (231(1)):36-50.35 doi:10.1016/j.ajog.2023.12.039.
PMID: 38191020 - 6
Short- and Long-term Outcomes of Postoperative Intrauterine Application of Hyaluronic Acid Gel: A Meta-analysis of Randomized Controlled Trials.
Dou Y, Yu T, Li Z, et al.
Journal of minimally invasive gynecology 2022; (29(8)):934-942 doi:10.1016/j.jmig.2022.05.006.
PMID: 35577245 - 7
Reproductive outcomes and reproductive tract microbiota shift in women with moderate-to-severe intrauterine adhesions following 30-day post-hysteroscopic placement of balloon stents or intrauterine contraceptive devices: A randomized controlled trial.
Wang Y, Zhao Y, Ge Y, et al.
EClinicalMedicine 2022; (43()):101200 doi:10.1016/j.eclinm.2021.101200.
PMID: 35128361 - 8
Extended intrauterine balloon stent use to prevent adhesion reformation after hysteroscopic adhesiolysis: a randomized trial.
Luo Y, Liu Y, Xiao Y, et al.
Fertility and sterility 2025; (124(1)):144-152 doi:10.1016/j.fertnstert.2025.01.024.
PMID: 39884334 - 9
Comparing durations of intrauterine balloon placement for intrauterine adhesions after hysteroscopic surgery: a systematic review and meta-analysis.
Xu P, Ling S, Hu E, et al.
BMC pregnancy and childbirth 2026; (26(1)).
PMID: 41654781 - 10
Extended balloon stent placement for reducing intrauterine adhesion recurrence: a retrospective cohort study.
Luo Y, Liu Y, Xie W, et al.
Reproductive biomedicine online 2024; (49(2)):103947 doi:10.1016/j.rbmo.2024.103947.
PMID: 38810315 - 11
Unintended pregnancy with retained intrauterine balloon after hysteroscopic adhesiolysis: a case report.
Liao Y, Xue C, Huang Y, et al.
Frontiers in medicine 2025; (12()):1685692 doi:10.3389/fmed.2025.1685692.
PMID: 41426606 - 12
A preliminary study on a patented intrauterine stent in the treatment of recurrent intrauterine adhesions with poor prognosis.
Huang H, Zou L, Zhang A, et al.
Annals of translational medicine 2020; (8(4)):57 doi:10.21037/atm.2020.01.77.
PMID: 32175351
This page is for informational purposes only and does not constitute medical advice. Your gynecologic surgeon should explain which barrier, duration, medicines, restrictions, and warning signs apply to your situation.
Get notified when new evidence is published on Asherman syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.